Class action lawsuits accuse DexCom and DXC Technology of securities fraud and misrepresentation.
Class action lawsuits filed against DexCom (DXCM) and DXC Technology Company (DXC) allege securities fraud and misrepresentation of ongoing "transformation journeys" and integration of acquired companies. DexCom's lawsuit focuses on alleged false statements in its Q2 2024 earnings, while DXC Technology's allegations include possible deferred cost reductions and limited integration efforts. Shareholders who purchased DXCM or DXC shares during the specified periods may be eligible for potential recovery.
August 05, 2024
4 Articles